521 total citations 24 papers, 440 citations indexed
About
Krakoff Ih is a scholar working on Molecular Biology, Oncology and Immunology.
According to data from OpenAlex, Krakoff Ih has authored 24 papers receiving a total of 440 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Oncology and 4 papers in Immunology. Recurrent topics in Krakoff Ih's work include Biochemical and Molecular Research (3 papers), Cancer Treatment and Pharmacology (3 papers) and Immunodeficiency and Autoimmune Disorders (2 papers). Krakoff Ih is often cited by papers focused on Biochemical and Molecular Research (3 papers), Cancer Treatment and Pharmacology (3 papers) and Immunodeficiency and Autoimmune Disorders (2 papers). Krakoff Ih collaborates with scholars based in United States. Krakoff Ih's co-authors include Lawrence Helson, Burchenal Jh, Stewart Ja, Hélène Savel, Wittes Re, Cheng Tan, Konstantin Mayer, Willi Kreis, Erlinda Etcubanas and Martin N. Raber and has published in prestigious journals such as PubMed.
In The Last Decade
Krakoff Ih
23 papers
receiving
389 citations
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
This map shows the geographic impact of Krakoff Ih's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Krakoff Ih with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Krakoff Ih more than expected).
This network shows the impact of papers produced by Krakoff Ih. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Krakoff Ih. The network helps show where Krakoff Ih may publish in the future.
Co-authorship network of co-authors of Krakoff Ih
This figure shows the co-authorship network connecting the top 25 collaborators of Krakoff Ih.
A scholar is included among the top collaborators of Krakoff Ih based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Krakoff Ih. Krakoff Ih is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
All Works
20 of 20 papers shown
1.
Pazdur, Richard, et al.. (1993). Clinical pharmacology of 11-acetyl-8-carbamoyloxymethyl-4-formyl-14-oxa-1,11-diazatetracyclo (7.4.1.0(2,7).0(10,12) tetradeca-2,4,6-trien-6,9-diyl diacetate (FK 973).. PubMed. 13(2). 343–6.1 indexed citations
2.
Ih, Krakoff. (1991). Gallium nitrate in the treatment of cancer-related hypercalcemia.. PubMed. 18(4 Suppl 5). 3–3.5 indexed citations
3.
Ring, Sigrid, et al.. (1987). Phase I clinical investigation of benzisoquinolinedione.. PubMed. 71(12). 1165–9.22 indexed citations
4.
Drewinko, Benjamin, et al.. (1986). Peplomycin and bleomycin effects on human colon cancer cells.. PubMed. 6(1). 1–3.1 indexed citations
5.
Copeland, L., et al.. (1984). Intermittent Iv homoharringtonine for the treatment of refractory epithelial carcinoma of the ovary: a phase II trial.. PubMed. 68(12). 1503–4.9 indexed citations
6.
Ja, Stewart, et al.. (1983). Effect of disulfiram on cyclophosphamide toxicity: a clinical trial.. PubMed. 67(12). 1145–7.3 indexed citations
7.
Griffin, J, et al.. (1982). Clinical and clinical pharmacologic studies of aziridinylbenzoquinone.. PubMed. 66(6). 1321–5.13 indexed citations
8.
Ja, Stewart, et al.. (1982). Clinical and clinical pharmacologic studies of mitoxantrone.. PubMed. 66(6). 1327–31.17 indexed citations
Ih, Krakoff, et al.. (1979). Phase I evaluation of tetrahydrouridine combined with cytosine arabinoside.. PubMed. 63(8). 1245–9.22 indexed citations
11.
Kreis, Willi, et al.. (1977). Tetrahydrouridine: Physiologic disposition and effect upon deamination of cytosine arabinoside in man.. PubMed. 61(7). 1347–53.20 indexed citations
12.
Ih, Krakoff, et al.. (1977). Physiologic disposition of cytosine arabinoside and its derivatives in man.. PubMed. 61(4). 723–6.5 indexed citations
13.
Re, Wittes, et al.. (1976). Trial of hydrazine sulfate (NSC-150014) in patients with cancer.. PubMed. 59(6). 1151–4.16 indexed citations
14.
Rb, Golbey, et al.. (1976). Combination chemotherapy with mitomycin C, 5-fluorouracil, and cytosine arabinoside in gastrointestinal cancer.. PubMed. 60(9). 1373–5.13 indexed citations
15.
Ih, Krakoff, et al.. (1968). Clinical studies of n-hydroxyurethan (NSC-83629).. PubMed. 52(6). 635–9.2 indexed citations
16.
Ih, Krakoff, et al.. (1967). Hyperuricosuria and central nervous system dysfunction.. PubMed. 92. 138–42.1 indexed citations
17.
Ih, Krakoff, et al.. (1965). STUDIES OF SERUM CHOLESTEROL LEVELS IN LEUKEMIA.. PubMed. 2. 8–14.12 indexed citations
18.
Ih, Krakoff, et al.. (1965). ENHANCED RETICULOENDOTHELIAL PHAGOCYTIC ACTIVITY IN MYELOPROLIFERATIVE DISEASES.. PubMed. 2. 1–7.7 indexed citations
19.
Ih, Krakoff, et al.. (1964). PHASE II STUDIES OF HYDROXYUREA (NSC-32065) IN ADULTS: CLINICAL EVALUATION.. PubMed. 40. 53–5.17 indexed citations
20.
Jh, Burchenal, et al.. (1960). The effects of epoxypropyl piperazine derivatives on a spectrum of transplanted mouse leukemias.. PubMed. 16. 556–60.1 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.